Eur Rev Med Pharmacol Sci 2022; 26 (24): 9457-9466
DOI: 10.26355/eurrev_202212_30697

Integrative oncology: evidence-based medicine – The multidisciplinary experience of the Integrative Medicine Research Group (IMRG)

M. Berretta, S. Cazzavillan, M. Tinazzi, A.M. Peire, D. Santangà, A. Bignucolo, M. Montopoli

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. berrettama@gmail.com


The purpose of this conference was to explain the relationship between the integrative and complementary medicine and cancer disease through evidence-based medicine. The topics covered are numerous and are characterized by the multidisciplinary approach of the researchers involved in this complex scenario. The Integrative Medicine Research Group (IMRG) studies the complementary and integrative approach in cancer patients with the aim to highlight the risk of drug and nutraceutical interactions and, at the same time, improve the quality of life in this particular set of patients. Our auspicious is to have an integrative medicine approach to all chronic diseases, oncological included.

Free PDF Download

To cite this article

M. Berretta, S. Cazzavillan, M. Tinazzi, A.M. Peire, D. Santangà, A. Bignucolo, M. Montopoli
Integrative oncology: evidence-based medicine – The multidisciplinary experience of the Integrative Medicine Research Group (IMRG)

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 24
Pages: 9457-9466
DOI: 10.26355/eurrev_202212_30697